Original Source(s)
Related Content
Case Report: Tislelizumab combined with bevacizumab in the treatment of primary malignant pericardial mesothelioma
June 16, 2026
Alectinib shows promise for the treatment of refractory ALK-positive large B-cell lymphoma: a case report
by Atheer Alsulami, Roula Almufti, Saleem Eldadah, Yahya Al-Ghamdi
June 17, 2026
Tissue-Resident NK Cells Slow Solid Tumor Growth in Mice
The study points to a possible off-the-shelf cell therapy for solid tumors
June 16, 2026
-
3 min
